引用本文:王秋娟,董火林,何伟峰.洛伐他汀治疗72例高血脂症的临床疗效与安全性观察[J].中国临床新医学,2009,2(7):718-720.
【打印本页】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 1204次   下载 968 本文二维码信息
码上扫一扫!
分享到: 微信 更多
洛伐他汀治疗72例高血脂症的临床疗效与安全性观察
王秋娟,董火林,何伟峰
454000 焦作,河南理工大学医院
摘要:
[摘要] 目的 观察洛伐他汀治疗72例高血脂症的临床疗效与安全性。方法 选择144例高血脂症患者,随机分为观察组与对照组,各72例。观察组采用洛伐他汀治疗,对照组不采用药物治疗。结果 观察组总有效率88.9%,观察组TC、TG 、LDL-C、LDL/HDL治疗后与治疗前及对照组相比,差异有统计学意义(P<0.05),所有患者在治疗过程中均无明显的毒副作用。结论 洛伐他汀治疗高血脂症具有良好的疗效与安全性。
关键词:  洛伐他汀  高血脂症  疗效  安全性
DOI:10.3969/j.issn.1674-3806.2009.07.21
分类号:R 541.4
基金项目:
Clinical effect and safety of Lovatation in the treatment of hyperlipidemia (Reports of 72 cases)
WANG Qiu-juan, DONG Huo-lin, HE Wei-feng
The Henan Polytechnic University, Jiaozuo Henan 454000, China
Abstract:
[Abstract] Objective To observe the clinical effect and safety of lovastatin in the treatment of 72 hyperlipidemia patients.Methods One hundred and forty-four hyperlipidemia patients were randomly divided into observation group (72 patients) and compared group (72 patients). The patients in observation group were treated with lovastatin, while those in the compared group were not treated with drugs.Results The total efficiency rate of observation group was 88.9%. The TC, TG, LDL-C, LDL/HDL of observation group after treatment were better than that of compared group (P<0.05). There was no distinct toxic and side effects.Conclusion Lovastatin treating the hyperlipidemia has good effect and safety.
Key words:  Lovatation  Hyperlipidemia  Efficacy  Safety